Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model. - Wikidata - awgldk - TriplyDB

Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model.

Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model.

http://www.wikidata.org/entity/Q36109993

about

Current advances in mathematical modeling of anti-cancer drug penetration into tumor tissues MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts.Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer Diffusion MRI and novel texture analysis in osteosarcoma xenotransplants predicts response to anti-checkpoint therapy F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy A linear algorithm of the reference region model for DCE-MRI is robust and relaxes requirements for temporal resolution A reference agent model for DCE MRI can be used to quantify the relative vascular permeability of two MRI contrast agents.Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts.Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma.Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy.Hypoxia Imaging With PET Correlates With Antitumor Activity of the Hypoxia-Activated Prodrug Evofosfamide (TH-302) in Rodent Glioma Models.Radiotherapy Synergizes with the Hypoxia-Activated Prodrug Evofosfamide: In Vitro and In Vivo Studies.

P2860

Q26827129-3502B12D-0819-43FE-B8FB-6E56ED51B333 Q31102361-606BD838-4FB0-4ACD-A874-36D58A3A3961 Q34756921-8518416B-8009-49A2-856F-77C716A545AF Q35072927-29729677-97BB-4C7A-843E-24E708F2408A Q35116993-86C338F6-21B4-4F7C-8977-7A6779C31C0A Q36803837-A02E6147-C963-4CFB-BB96-DACDAAEA4B8A Q37039971-B003A0A8-7788-4D22-AF54-E0BB8DD093AD Q38665197-BDE9DA77-BB42-48B3-A40B-8AB516DBDE97 Q38957729-2CEE06C9-F93E-4E76-9FD3-0635529D6D4D Q39110234-883E3A10-09BD-48DA-BA3C-5798AAD4FFE5 Q41467964-3D6821CE-FE1E-4B70-B37B-CAA910ED7FF8 Q46018609-15F96A5A-9814-4A09-A70C-DE66D4168D80

P2860

Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model.

http://www.wikidata.org/entity/Q36109993

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Imaging biomarkers to monitor ...... iaPaCa2 flank xenograft model.

@ast

Imaging biomarkers to monitor ...... iaPaCa2 flank xenograft model.

@en

type

label

Imaging biomarkers to monitor ...... iaPaCa2 flank xenograft model.

@ast

Imaging biomarkers to monitor ...... iaPaCa2 flank xenograft model.

@en

prefLabel

Imaging biomarkers to monitor ...... iaPaCa2 flank xenograft model.

@ast

Imaging biomarkers to monitor ...... iaPaCa2 flank xenograft model.

@en

P1433

Q36109993-3D14F88C-7B9D-4298-A275-1C467956E8C0

P1476

Q36109993-657765C2-7FC6-490C-8DE2-D881AEDD3ECC

P2093

Q36109993-03647FC7-3C68-4747-9D43-7823E19DAC38

Q36109993-4643632D-8606-4652-8922-1F7A49509666

Q36109993-587BE6B6-DE1F-4835-BFAC-1057414EB92E

Q36109993-C11CEA1B-745C-4A82-A979-CBFAB1E2F447

Q36109993-D573D700-B95E-48E3-8BCC-187ACB905D1E

Q36109993-E6F13177-71CF-4EC9-9D82-B18AA0FD3E72

Q36109993-F1A7BEB4-8DCE-4001-B78E-9DF161830C4B

P2860

Q36109993-052922A6-0EE6-4E15-9F6F-E826A347D04A

Q36109993-281C3B57-B2CC-49DA-AA27-63997232B5E7

Q36109993-35607689-D07C-4D07-AC36-6C486B65B732

Q36109993-4966EBB6-8011-44C2-8987-E46DC10E8847

Q36109993-67F515CF-F9CE-4D57-BAE4-A7A1854E4994

Q36109993-70BCCE10-3869-4158-A0E0-1D34E4877370

Q36109993-7B3CE4B4-6C7B-4086-A97D-6E423FAB3A78

Q36109993-7EF8D7CD-3A57-4106-8B26-6389C63146D8

Q36109993-818A2AAD-75D1-444D-808E-68A6D2B1CC95

Q36109993-90A0025D-5DA9-4544-AE4E-835C68443F28

P304

Q36109993-C48E27CF-0E30-408A-ABDE-F0CDDDCBA373

P31

Q36109993-4B681F65-59EE-45A3-A9EC-EA8CC4EF90B1

P356

Q36109993-96BC49C8-9256-4028-9BF2-85E7B6643FF4

P433

Q36109993-B8CAA8AE-9551-404F-AE01-C0D2F6D73694

P478

Q36109993-87E2297C-AED1-4BEE-A475-D595D4712232

P577

Q36109993-22426512-1946-46E5-86AD-1DA7992FC3ED

P5875

Q36109993-7C58297F-B559-4528-850A-0FD5D28B78FE

P698

Q36109993-98569C1C-D5E9-4CB0-A95A-B6A50EBD83B4

P921

Q36109993-3B8F9E03-F80F-48B4-9071-DE0178E2CC15

Q36109993-AE5ED3FD-7633-486F-9FE5-8D60BFCE5AB6

Q36109993-B0950879-1B59-4131-88AA-C3D32D27435C

P932

Q36109993-C69BCD13-1EF8-43CE-9E17-A18939759F39

P356

J.MRI.2012.02.015

P1433

Magnetic Resonance Imaging

P1476

Imaging biomarkers to monitor ...... iaPaCa2 flank xenograft model.

@en

P2093

Amanda F Baker

http://www.w3.org/2001/XMLSchema#string

Heather Cornnell

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Galons

http://www.w3.org/2001/XMLSchema#string

Julio Cárdenas-Rodríguez

http://www.w3.org/2001/XMLSchema#string

Mark D Pagel

http://www.w3.org/2001/XMLSchema#string

Robert J Gillies

http://www.w3.org/2001/XMLSchema#string

Yuguo Li

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

High-resolution diffusion imaging with DIFRAD-FSE (diffusion-weighted radial acquisition of data with fast spin-echo) MRI.

Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.

Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.

MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms.

Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples

Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat glioma

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Applications of magnetic resonance in model systems: cancer therapeutics

Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs.

P304

1002-1009

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MRI.2012.02.015

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224896318

http://www.w3.org/2001/XMLSchema#string

P698

22554971

http://www.w3.org/2001/XMLSchema#string

P921

P932

3402593

http://www.w3.org/2001/XMLSchema#string